Why Fiat (FIATY) Stock Is Down Today

NEW YORK (TheStreet) -- Shares of FIAT  (FIATY) are down -4.95% to $8.65 in heavy trading volume over concerns that shareholders will prevent its merger with Chrysler Group as the U.S. car maker reported that second quarter profit was up 22% to $619 million.

Chrysler reported a 14% increase in net revenue to $20.5 billion, and confirmed its full year outlook that includes adjusted net income between $2.3 billion and $2.5 billion on net revenue of about $80 billion.

Concerns are that investors who voted against the merger with Chrysler would exercise their right to sell the stock, potentially jeopardizing the tie-up, Reuters reports.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The merger is still subject to some conditions, including a limit on the number of dissenting shareholders who exercise their right to sell out, Reuters said.

Barclays (BCS), in a research note said said that in its view it would "be quite tough to reach the threshold" of shareholders to prevent the merger. 

FIATY ChartFIATY data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

China Slashes Auto Import Tariffs as Trump's Trade Push Gets Big Early Win

China Slashes Auto Import Tariffs as Trump's Trade Push Gets Big Early Win

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Global Stocks Ease as Investors Focus on Dollar, Oil, Italy After US-China Truce

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes